Cargando…

Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy

One strategy in cancer immunotherapy is to capitalize on the key immunoregulatory and antigen presenting capabilities of dendritic cells (DCs). This approach is dependent on efficient delivery of tumor specific antigens to DCs, which subsequently induce an anti-tumor T-cell mediated immune response....

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkinson-Ryan, Ivy, Kim, Julius, Kim, Sojung, Ak, Ferhat, Dodson, Lindzy, Colonna, Marco, Powell, Matthew, Mutch, David, Spitzer, Dirk, Hansen, Ted, Goedegebuure, Simon P., Curiel, David, Hawkins, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416912/
https://www.ncbi.nlm.nih.gov/pubmed/25933160
http://dx.doi.org/10.1371/journal.pone.0125851
_version_ 1782369297268473856
author Wilkinson-Ryan, Ivy
Kim, Julius
Kim, Sojung
Ak, Ferhat
Dodson, Lindzy
Colonna, Marco
Powell, Matthew
Mutch, David
Spitzer, Dirk
Hansen, Ted
Goedegebuure, Simon P.
Curiel, David
Hawkins, William
author_facet Wilkinson-Ryan, Ivy
Kim, Julius
Kim, Sojung
Ak, Ferhat
Dodson, Lindzy
Colonna, Marco
Powell, Matthew
Mutch, David
Spitzer, Dirk
Hansen, Ted
Goedegebuure, Simon P.
Curiel, David
Hawkins, William
author_sort Wilkinson-Ryan, Ivy
collection PubMed
description One strategy in cancer immunotherapy is to capitalize on the key immunoregulatory and antigen presenting capabilities of dendritic cells (DCs). This approach is dependent on efficient delivery of tumor specific antigens to DCs, which subsequently induce an anti-tumor T-cell mediated immune response. Human adenovirus serotype 5 (HAdV5) has been used in human studies for gene delivery, but has limited infection in DCs, which lack the proper receptors. Addition of the porcine fiber knob (PK) from porcine adenovirus type 4 to HAdV5 allows the virus to deliver genetic material via binding to glycosylated surface proteins and bypasses the coxsackie-and-adenovirus receptor required by wild-type HAdV5. In this study we explored the potential therapeutic applications of an adenovirus with PK-based tropism against cancers expressing mesothelin. Infectivity and gene transfer assays were used to compare Ad5-PK to wild-type HAdV5. Mouse models were used to demonstrate peptide specificity and T-cell responses. We show that the PK modification highly augmented infection of DCs, including the CD141+ DC subset, a key subset for activation of naïve CD8+ T-cells. We also show that Ad5-PK increases DC infectivity and tumor specific antigen expression. Finally, vaccination of mice with the Ad5-PK vector resulted in enhanced T-cell-mediated interferon gamma (IFN-γ) release in response to both mesothelin peptide and a tumor line expressing mesothelin. Ad5-PK is a promising tool for cancer immunotherapy as it improves infectivity, gene transfer, protein expression, and subsequent T-cell activation in DCs compared to wild-type HAdV5 viruses.
format Online
Article
Text
id pubmed-4416912
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44169122015-05-07 Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy Wilkinson-Ryan, Ivy Kim, Julius Kim, Sojung Ak, Ferhat Dodson, Lindzy Colonna, Marco Powell, Matthew Mutch, David Spitzer, Dirk Hansen, Ted Goedegebuure, Simon P. Curiel, David Hawkins, William PLoS One Research Article One strategy in cancer immunotherapy is to capitalize on the key immunoregulatory and antigen presenting capabilities of dendritic cells (DCs). This approach is dependent on efficient delivery of tumor specific antigens to DCs, which subsequently induce an anti-tumor T-cell mediated immune response. Human adenovirus serotype 5 (HAdV5) has been used in human studies for gene delivery, but has limited infection in DCs, which lack the proper receptors. Addition of the porcine fiber knob (PK) from porcine adenovirus type 4 to HAdV5 allows the virus to deliver genetic material via binding to glycosylated surface proteins and bypasses the coxsackie-and-adenovirus receptor required by wild-type HAdV5. In this study we explored the potential therapeutic applications of an adenovirus with PK-based tropism against cancers expressing mesothelin. Infectivity and gene transfer assays were used to compare Ad5-PK to wild-type HAdV5. Mouse models were used to demonstrate peptide specificity and T-cell responses. We show that the PK modification highly augmented infection of DCs, including the CD141+ DC subset, a key subset for activation of naïve CD8+ T-cells. We also show that Ad5-PK increases DC infectivity and tumor specific antigen expression. Finally, vaccination of mice with the Ad5-PK vector resulted in enhanced T-cell-mediated interferon gamma (IFN-γ) release in response to both mesothelin peptide and a tumor line expressing mesothelin. Ad5-PK is a promising tool for cancer immunotherapy as it improves infectivity, gene transfer, protein expression, and subsequent T-cell activation in DCs compared to wild-type HAdV5 viruses. Public Library of Science 2015-05-01 /pmc/articles/PMC4416912/ /pubmed/25933160 http://dx.doi.org/10.1371/journal.pone.0125851 Text en © 2015 Wilkinson-Ryan et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wilkinson-Ryan, Ivy
Kim, Julius
Kim, Sojung
Ak, Ferhat
Dodson, Lindzy
Colonna, Marco
Powell, Matthew
Mutch, David
Spitzer, Dirk
Hansen, Ted
Goedegebuure, Simon P.
Curiel, David
Hawkins, William
Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
title Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
title_full Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
title_fullStr Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
title_full_unstemmed Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
title_short Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
title_sort incorporation of porcine adenovirus 4 fiber protein enhances infectivity of adenovirus vector on dendritic cells: implications for immune-mediated cancer therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416912/
https://www.ncbi.nlm.nih.gov/pubmed/25933160
http://dx.doi.org/10.1371/journal.pone.0125851
work_keys_str_mv AT wilkinsonryanivy incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT kimjulius incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT kimsojung incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT akferhat incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT dodsonlindzy incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT colonnamarco incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT powellmatthew incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT mutchdavid incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT spitzerdirk incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT hansented incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT goedegebuuresimonp incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT curieldavid incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy
AT hawkinswilliam incorporationofporcineadenovirus4fiberproteinenhancesinfectivityofadenovirusvectorondendriticcellsimplicationsforimmunemediatedcancertherapy